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C
DObjective: Robotic-assisted coronary artery bypass grafting has emerged as an alternative to traditional
coronary artery bypass grafting or percutaneous intervention for patients with coronary artery disease.
However, the safety and efficacy of this minimally invasive procedure have not been established in large series.
Methods: From October 2009 to September 2012, 307 consecutive robotic-assisted coronary artery bypass
grafting procedures were performed at a single US institution by 2 surgeons. Isolated, off-pump, left
internal thoracic artery to left anterior descending coronary artery grafting was planned via a 3- to 4-cm
non–rib-spreading minithoracotomy after robotic left internal thoracic artery harvest in all patients. Hybrid
coronary revascularization was planned in 159 patients (51.8%). Of the 199 angiograms (64.8%) performed
before discharge, 63 were performed as completion angiograms in a hybrid suite immediately after left internal
thoracic artery–left anterior descending artery grafting.
Results: Thirty-day mortality occurred in 4 patients (1.3%), conversion to sternotomy occurred in 16 patients
(5.2%), postoperative myocardial infarction occurred in 5 patients (1.6%), and reexploration for bleeding
occurred in 7 patients (2.3%). There was 1 (0.3%) postoperative stroke. For the 199 patients with follow-up
angiography before discharge, the left internal thoracic artery was confirmed to be patent (<50% stenosis) in
189 patients (95.0%). Among the 10 patients with significant (50% stenosis) defects, 5 had graft occlusion
or distal left anterior descending occlusion, 2 had poor flow distal to the anastomosis, and 3 had anastomotic
lesions (50% stenosis). Among the 63 patients with intraoperative completion angiography, 5 patients
underwent surgical graft revision, 3 patients underwent minithoracotomy, and 2 patients underwent conversion
to sternotomy.
Conclusions: Robotic-assisted coronary artery bypass grafting is an effective alternative to traditional coronary
artery bypass grafting for patients with single or multivessel coronary artery disease, with comparable short-term
clinical and angiographic results. (J Thorac Cardiovasc Surg 2014;147:179-85)Coronary artery bypass grafting (CABG) is an established
method of treating patients with coronary artery
disease, with recent trials reemphasizing its efficacy and
durability.1,2 An important component of the benefit
conferred by CABG is derived from the left internal
thoracic artery (LITA) graft to the left anterior descending
(LAD) coronary artery. Minimally invasive approaches to
CABG have become more commonplace, fueled in part
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The Journal of Thoracic and Casignificant technologic advances in robotics, perfusion
devices, off-pump CABG, and retraction systems.
The 3 most common minimally invasive CABG
procedures use a sternal-sparing approach and include
minimally invasive direct coronary artery bypass
(MIDCAB), robotic-assisted coronary artery bypass
(CAB), and robotic-assisted totally endoscopic coronary
artery bypass (TECAB). Each approach has unique
advantages and disadvantages, but results have been
excellent when performed by experienced surgeons.
Robotic-assisted CAB capitalizes on the main advantage
of surgical revascularization, the LITA-LAD graft; although
diagonal grafting is also possible, circumflex and right
coronary vessels are usually treated with percutaneous
coronary intervention (PCI) when robotic-assisted
LITA-LAD grafting is performed in patients with multi-
vessel disease. The LITA harvest, pericardiotomy, and
LAD identification are accomplished with robotic
assistance, but the anastomosis is performed manually,
under direct vision, through a non–rib-spreading 3- to
4-cm anterolateral thoracotomy without the use of
cardiopulmonary bypass. The purpose of this analysis isrdiovascular Surgery c Volume 147, Number 1 179
Abbreviations and Acronyms
CAB ¼ coronary artery bypass
CABG ¼ coronary artery bypass grafting
LAD ¼ left anterior descending
LITA ¼ left internal thoracic artery
MIDCAB ¼ minimally invasive direct coronary
artery bypass
OR ¼ operating room
PCI ¼ percutaneous coronary intervention
PROM ¼ predicted risk of mortality
TECAB ¼ totally endoscopic coronary artery
bypass
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Dto describe the short-term clinical and angiographic
results in a large consecutive cohort of patients undergoing
robotic-assisted CAB for both isolated LAD and multi-
vessel disease.MATERIALS AND METHODS
Patients and Design
During the 37-month period between October 2009 and September
2012, data from 307 consecutive patients undergoing robotic-assisted
CAB were prospectively entered into a customized database that included
operative, technical, and angiographic details that were not available from
the Society of Thoracic Surgeons (STS) database. This database was then
merged with data from the STS database and retrospectively reviewed. All
consecutive cases from 2 surgeons, including the earliest learning curve
cases, were included in the analysis. The institutional review board at
Emory University in compliance with Health Insurance Portability and
Accountability Act regulations and the Declaration of Helsinki approved
the study. The institutional review board waived the need for individual
patient consent.
Indications and Contraindications
Patients eligible for robotic-assisted CAB had clinical and anatomic
indications for surgical coronary revascularization. These patients
(1) presented with isolated LAD that was not amenable to PCI or had
LAD disease that was considered better treated with LITA-LAD grafting
or (2) presented with multivessel coronary disease that was amenable to
a hybrid revascularization approach, defined as LITA-LAD grafting
combined with PCI of non-LAD lesions.
Absolute contraindications to robotic-assisted CAB included
hemodynamically unstable patients, those with intra-aortic balloon pumps,
or those with evolving myocardial infarction. Patients with a poor or
nongraftable distal target vessel, previous sternotomy or thoracotomy,
body mass index greater than 40, or severe lung disease with inability to
tolerate single-lung ventilation were considered relative contraindications.
Technical Details
All patients underwent single lung ventilation using a dual lumen
endotracheal tube or bronchial blocker or bilateral lung low tidal volume
ventilation. Beta-blockers were administered within 24 hours of the
procedure. Aspirin 1000 mg was administered per rectum after induction.
Before dividing the LITA, 180 IU/kg of intravenous heparin is
administered to achieve an activated clotting time greater than 350 seconds.
The patient is positioned with a roll under the left chest beneath the scapula
to allow the left shoulder to be lowered when the left upper extremity is180 The Journal of Thoracic and Cardiovascular Surgtucked loosely. A 12-mm thoracoscopic trocar is inserted into the
fourth or fifth interspace, in the midportion of the sternum, approximately
2 fingerbreadths lateral to the midclavicular line. Ideally, the camera port is
inserted at the location that is at a 45-degree angle to the plane of the
sternum. This allows optimal visualization of the LITA but adequate
distance away from it to allow for easy dissection. Before inserting the
trocar, the ventilator is disconnected allowing the heart to fall toward the
right hemithorax. The chest is initially entered with a blunt instrument to
prevent ventricular or pulmonary injury with port placement. After the
trocar is inserted, the chest is insufflated with carbon dioxide at 10 to
15 mm Hg, and the right lung is ventilated. An 8.5-mm trocar is placed 2
interspaces above the camera port under direct vision slightly medial to
the camera port. The final 8.5-mm trocar is placed 2 interspaces below
the camera port in line or slightly medial to the camera port. The da Vinci
Robotic surgical system (Intuitive Surgical, Sunnyvale, Calif) is then
docked and instruments inserted under direct vision. The surgeon then
scrubs out, and the LITA is harvested using both the robotic monopolar
cautery spatula and the bipolar cautery forceps. In general, the LITA is
harvested in a semiskeletonized fashion. Overlying muscle and fascia are
removed only to provide complete exposure during the harvest. After
LITA harvest, pericardial fat is dissected off the pericardium and draped
laterally. A small pericardiotomy posterior to the left phrenic nerve can
be performed to facilitate pericardial drainage. A full longitudinal
pericardiotomy is then performed anteriorly, and the LAD is identified
and inspected for a suitable grafting site. The LITA is divided distally
between clips after systemic heparinization and clipped to the edge of
the pericardium or allowed to fall toward the apex.
At this point, the robotic system is undocked, and the surgeon uses the
endoscope to identify the planned site of anastomosis without carbon
dioxide insufflation. This allows the heart to return to its natural position
within the chest. A spinal needle is inserted through the chest wall to
identify the precise location for the incision over the target LAD site.
In female patients, the breast is usually retracted medially for the robotic
portion of the procedure and then repositioned superiorly/laterally to
facilitate an infrathoracic incision if feasible. All ports are then removed,
and the anterolateral thoracotomy incision is made. A soft tissue retractor
(CardioVations, Edwards Lifesciences, Irvine, Calif) is used to provide
exposure through the interspace. Rib spreading is avoided. The LITA is
retrieved into the operating field and prepared. The LAD target is exposed
and stabilized using a minimally invasive stabilizer (Octopus NUVO,
Medtronic, Inc, Minneapolis, Minn), and the anastomosis is performed
manually off-pump using fine 8-0 monofilament suture.
Angiography
Since September 2010, it has been our preference to use a hybrid
operating room (OR) when available to perform completion angiograms
or 1-stop hybrid revascularization when indicated. During our initial
experience, we routinely performed selective LITA angiography in the
postoperative period to assess graft patency. Patency was defined as less
than 50% stenosis in the graft or at the anastomosis. For cases in which
a completion angiogram in the hybrid suite revealed graft defects or target
vessel errors, the anastomosis was revised during the same operative
setting, regardless of whether there was clinical evidence of ischemia.RESULTS
From October 2009 to September 2012, 307 patients
underwent planned robotic-assisted CAB with LITA-LAD
grafting. In all patients, the intention was LITA-LAD
grafting as an isolated procedure (148, 48.2%) or as
part of a hybrid coronary revascularization strategy for
multivessel coronary disease (159, 51.8%). All consecutive
cases for 2 surgeons during this interval were includedery c January 2014
TABLE 2. Conversion to sternotomy
Reasons for conversion to sternotomy N ¼ 16
Technical difficulty with LITA-LAD anastomosis 6
LITA injury/dissection/inadequate length 3
Wrong vessel grafted 2
Ventricular arrhythmia 1
Equipment malfunction 1
Right ventricular epicardial injury from port placement 1
Halkos et al Acquired Cardiovascular Disease(surgeon 1, 235 cases; surgeon 2, 72 cases), which includes
learning curve cases and represents the early experience of
our robotic-assisted CAB program. Of the 228 cases
performed after September 2010, 188 of these were
performed in the hybrid OR. Concomitant or ‘‘1-stage’’
hybrid revascularization procedures were performed in
21 patients, and intraoperative completion angiograms
were performed in 63 patients.Bleeding during LITA harvest 1
Left chest adhesions 1
LAD, Left anterior descending coronary artery; LITA, left internal thoracic artery.Demographic and Patient Variables
The mean age was 62.7  11.6 years, 71.3% of
patients were female, and the mean ejection fraction was
55.5%  8.7%. The mean STS predicted risk of mortality
(PROM) score was 1.2%  1.7%, and the predicted risk
of permanent stroke was 0.97%  1.0%. There were 50
patients (16.3%) with STS PROM scores more than
2.0%, 13 of whom had STS PROM scores more than 5%.
Other demographic variables are listed in Table 1.A
C
DClinical Outcomes
Thirty-day mortality occurred in 4 patients (1.3%),
conversion to sternotomy occurred in 16 patients (5.2%),
postoperative myocardial infarction occurred in 5 patients
(1.6%), and reexploration for bleeding occurred in 7
patients (2.3%). Reasons for conversion to sternotomy are
described in Table 2. None of the postoperative deaths
were due to graft failure. There was only 1 (0.3%)
postoperative stroke, which was nonembolic and related
to a brief period of postoperative hypotension in a patient
who had a history of previous stroke. The incidence of
blood transfusion was low, with only 66 patients (21.5%)
receiving any blood transfusion. Postoperative repeat
revascularization occurred in 8 of 307 patients (2.6%).TABLE 1. Demographic and clinical baseline characteristics
Variable N ¼ 307
Age (y) 62.7  11.6
Male/female ratio 219/88
Body mass index 28  4.7
Smoker 79 (25.7%)
Diabetes 109 (35.5%)
Dyslipidemia 296 (96.4%)
Hypertension 282 (91.9%)
Peripheral vascular disease 38 (12.4%)
Previous stroke 12 (3.9%)
Renal failure-hemodialysis 10 (3.3%)
NYHA class III-IV 10 (3.3%)
Prior myocardial infarction 161 (52.4%)
Ejection fraction 55.5%  8.7%
Left main disease 37 (12.1%)
STS PROM 1.2%  1.7%
STS PROPS 0.97%  1.0%
NYHA, New York Heart Association; PROM, predicted risk of mortality;
PROPS, predicted risk of postoperative stroke; STS, Society of Thoracic Surgeons.
The Journal of Thoracic and CaReintubation occurred in 4 of 123 patients who were
extubated in the OR. Additional outcomes can be seen in
Table 3. Outcomes among patients with STS PROM scores
of 2.0% or greater are shown in Table 4.Angiographic Outcomes
Graft defects, determined by intraoperative and post-
operative angiography, were identified in 14 of 199 patients
(7.0%) (Figure 1). This included 10 patients with nonpatent
grafts (stenosis 50%) and 4 patients with target vessel
errors. Overall, 189 of 199 grafts (95.0%) were patent
(<50% stenosis). According to Fitzgibbon criteria to define
patency, Fitzgibbon A þ B patency was 96.5% (192/199
patients). In the 10 patients with graft failure, 5 had
occluded grafts, 2 had poor flow distal to the anastomosis,
and 3 had anastomotic stenosis. However, 3 of these grafts
were revised during the same operative setting after the
completion angiogram. Graft failure was noted in the other
7 patients on postoperative angiograms done before hospital
discharge; 6 patients were treated percutaneously, and 1
patient underwent redo-multivessel CABG. Only 3 of theseTABLE 3. Clinical outcomes of entire cohort
Outcome N ¼ 307
30-d mortality 4 (1.3%)
Stroke 1 (0.3%)
Myocardial infarction 5 (1.6%)
Conversion to sternotomy 16 (5.2%)
Reexploration for bleeding 7 (2.3%)
Repeat revascularization 8 (2.6%)
Postoperative atrial fibrillation 47 (15.3%)
Renal failure 6 (2.0%)
No. of patients receiving any blood product
transfusion
66 (21.5%)
Superficial wound infection 6 (2.0%)
Sternal complications/mediastinitis 0
Extubated in OR 123 (40.0%)
Prolonged ventilation (>24 h) 18 (5.9%)
Median ventilation time 2.0 h (range, 0-193)
Median ICU length of stay 1.0 d (range, 0-19)
Median hospital length of stay 4.0 d (range, 2-27)
ICU, Intensive care unit; OR, operating room.
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TABLE 4. Clinical outcomes of high-risk patients (Society of Thoracic
Surgeons predicted risk of mortality 2.0%)
Outcome N ¼ 50
Mean STS PROM score 4.3%  2.5%
30-d mortality 1 (2.0%)
Stroke 1 (2.0%)
Myocardial infarction 1 (2.0%)
Conversion to sternotomy 3 (6.0%)
Reexploration for bleeding 1 (2.0%)
Repeat revascularization 0
Postoperative atrial fibrillation 13 (26.0%)
Renal failure 3 (6.0%)
No. of patients receiving any blood product
transfusion
20 (40.0%)
Superficial wound infection 0
Sternal complications/mediastinitis 0
Extubated in OR 14 (28.0%)
Prolonged ventilation (>24 h) 6 (12.0%)
Median ventilation time 6.3 h (range, 0-114)
Median ICU length of stay 2.0 d (range, 0-17)
Median hospital length of stay 6.0 d (range, 2-27)
ICU, Intensive care unit; OR, operating room; STS, Society of Thoracic Surgeons;
PROM, predicted risk of mortality.
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D10 patients had clinical evidence of ischemia. Therefore,
of the 8 patients who underwent repeat revascularization,
6 underwent PCI for graft failure, 1 underwent PCI for
target vessel error (inadvertent LITA-diagonal grafting),
and 1 underwent redo-multivessel CABG for graft failure.
The diagonal rather than the LAD coronary artery was
inadvertently grafted in 4 patients. In 2 of these patients,
the patent LITA-diagonal grafts were discovered on the
intraoperative completion angiogram, which allowed for
revision in the hybrid OR under the same anesthesia setting.
The other 2 patients were found to have patent diagonalFIGURE 1. Flow diagram of patients undergoing robotic-assisted CABG cat
CABG, coronary artery bypass grafting; LAD, left anterior descending; PCI, pe
182 The Journal of Thoracic and Cardiovascular Surggrafts on staged postoperative angiography; 1 had a stent
placed in the proximal LAD because of an intervening
lesion between the diagonal and LAD arteries.
Therefore, procedural success, defined as patients lea-
ving the OR with patent grafts (<50% stenosis) to planned
target vessels, was 95.5% (190/199). This takes into
account the 5 grafts that were revised in the OR and the
2 inadvertent diagonal grafts that were discovered on
postoperative angiogram. Alternatively, if Fitzgibbon
criteria were used to define graft patency (Fitzgibbon
A þ B), the procedural success was 97.0% (193/199).
Learning Curve
In this study, procedural times for each surgeon steadily
declined (Figure 2). For surgeon 1 (MH, 235 cases), the
mean procedure time (incision to close) for the last 10 cases
was 178 minutes. For surgeon 2, (JP, 72 cases), the mean
procedure time for the last 10 cases was 219 minutes, but
the learning curves are well matched according to case
volume. For patients undergoing 1-stop or concomitant
hybrid coronary revascularization, the mean time for both
surgery and PCI was 281 minutes. For the first 153 cases,
there were 9 graft defects (5.9%); for the last 154 cases,
there were 5 graft defects (3.2%). Conversions occurred
in 9 (5.9%) of the first 153 cases and 7 (4.5%) of the last
154 cases.
DISCUSSION
Minimally invasive CAB procedures have become
an accepted method of surgical revascularization. By
capitalizing on the proven durability and survival advantage
associated with LITA-LAD grafting, these less-invasive
surgical options can be applied to patients with
isolated LAD ormultivessel coronary disease. Furthermore,egorized by angiography and graft defects. CAB, Coronary artery bypass;
rcutaneous coronary intervention.
ery c January 2014
FIGURE 2. Plot of surgery time versus log of case experience revealed statistically significant effect of experience on duration of operation.
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Dcardiologists may be more willing to refer patients for
this approach providing patients with the best available
treatment option for the LAD, the LITA. Although a
nonrobotic approach represents a viable alternative to
sternotomy, robotic techniques provide high-definition
intrathoracic exposure and 3-dimensional telemanipulation
for LITA harvest, pericardiotomy, and totally endoscopic
multivessel grafting. Nonetheless, for less-invasive surgical
revascularization options to become widely adopted, both
clinical and angiographic outcomes need to be comparable
to more conventional sternotomy approaches.
In this study, isolated off-pump LITA-LAD grafting
was performed via a sternal-sparing, non–rib-spreading
3- to 4-cm anterolateral thoracotomy after robotic LITA
harvest and pericardiotomy. In contrast to TECAB, all
anastomoses were performed manually with direct vision,
in a manner similar to that performed via sternotomy. The
main disadvantages of this approach are limited exposure
of the entire LAD and the inability to graft other major
coronary territories. The main advantage is that the
operation is less technically challenging than TECAB,
avoiding the need for advanced skills required for robotic
anastomosis and perfusion techniques, and avoiding larger
incisions and chest wall retraction associated with MID-
CAB. For patients suitable for a hybrid revascularization
strategy, percutaneous intervention with stenting of
non-LAD lesions can be combined with robotic-assistedThe Journal of Thoracic and CaLITA-LAD grafting. The benefits of a hybrid approach
for multivessel disease will need to be validated in clinical
trials.
The clinical results of this series are comparable to those
of other published results. For MIDCAB, Holzhey and
colleagues3 demonstrated a postoperative LITA-LAD
patency rate of 95.5%, perioperative stroke and mortality
rate of less than 1%, and a conversion rate of 1.8%.
McGinn and colleagues4 reported excellent short-term
results with multivessel grafting via a MIDCAB incision
with a perioperative mortality rate of 1.3%, conversion
rate of 3.8%, and reoperation rate for bleeding of 2.2%.
For TECAB procedures, Bonatti and colleagues5 reported
results in more than 400 TECAB cases with a 0.7%
mortality, 14% conversion rate, and 1.7% stroke rate.
Other centers also have reported excellent short-term
outcomes.6-12 Postoperative stroke, one of the main
limitations of CABG compared with PCI,1,2 occurred in
only 1 patient in this series and was nonembolic in cause.
Compared with TECAB and multivessel MIDCAB
approaches, the revascularization strategy described in our
series avoids any manipulation of the ascending aorta
and avoids antegrade or retrograde perfusion with
cardiopulmonary bypass, which may minimize the risk of
atheroembolic stroke. Furthermore, this approach avoids
the larger incision, chest wall retraction, and possible rib
fracture associated with MIDCAB techniques, whichrdiovascular Surgery c Volume 147, Number 1 183
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Dtheoretically would imply less postoperative pain. With this
less-invasive approach, atrial fibrillation occurred in only
15% of patients, which may affect longer-term stroke rates.
Likewise, other resource use measures were favorable for
this study.
It is important to compare the clinical outcomes of
less-invasive approaches with traditional CABG13-15;
however, the most discriminatory outcome measure that
warrants comparison is graft quality and patency. Despite
the availability of computed tomography angiography and
intraoperative transit time flow measurements, the most
reliable method of documenting the quality of the
anastomosis is conventional angiography. In this series,
199 patients underwent intraoperative or postoperative
angiography. In our experience, LITA angiograms were
routinely performed in our first 150 cases and are
always performed as part of hybrid revascularization
procedures when the surgical session is performed first or
concomitantly with PCI of non-LAD vessels.
With a hybrid OR, completion angiograms can be
performed under anesthesia, which allows for surgical
revision when graft defects are identified. Zhao and
colleagues16 reported that 12% of bypass grafts had defects
or target vessel errors identified on completion angiography
before sternotomy closure, with 9.4% undergoing surgical
revision or open PCI. Findings detected on completion
angiograms in the current study led to graft revision in 5
of 63 cases (7.9%), which may have prevented adverse
clinical outcomes and graft failure. It is possible that our
overall angiographic outcomes would have been better if
all cases could have been performed in a hybrid OR, which
was not available until the second year of our program.
From a practical standpoint, this may not always be
possible, because hybrid rooms are used by other services
and for other procedures, and require considerable financial
resources to develop and maintain. Nonetheless, the ability
to perform completion angiograms for procedures without
an established track record has been an important part of
our learning curve and quality control, and has been vital
for programmatic growth. Our current policy is to perform
completion angiography in cases in which there are any
concerns about the quality of the graft, anastomosis, or
target vessel, and in all technically challenging cases.
This includes chronically occluded LAD arteries and small,
calcified, or diffusely diseased target vessels, regardless of
transit time flow measurements or clinical status.
There is undoubtedly a learning curve that exists for
any minimally invasive CABG procedure.17 Holzhey and
colleagues18 were able to demonstrate that outcomes after
MIDCAB were surgeon and case-load dependent, requiring
up to 50 to 100 cases to achieve proficiency. Wiedemann
and associates19 confirmed that more complex TECAB
procedures result in longer operative times, which may
adversely influence postoperative outcomes. Our results184 The Journal of Thoracic and Cardiovascular Surgmirror those of other studies. With this approach, there
are 2 portions of the procedure associated with a learning
curve: (1) the robotic LITA harvest and pericaridotomy;
and (2) off-pump LITA-LAD grafting via a small
anterolateral thoracotomy. Both surgeons in this study had
extensive off-pump experience via sternotomy before
adopting this approach, which undoubtedly improved the
proficiency of off-pump LITA-LAD grafting via a small
thoracotomy. Both of the surgeons in this study had limited
MIDCAB experience. We observed a gradual reduction in
the length of operation with increasing surgical experience
and fewer errors with increasing experience. Our results
suggest that at least 50 to 100 cases are required to achieve
proficiency, which depends not only on the individual
surgeon but also on the entire cardiovascular team.
Although target vessel errors can occur during 1% to 2%
of sternotomy cases,16 this error is easier to make with a
robotic-assisted approach. With TECAB, all coronary
territories can be visualized, but during robotic-assisted or
MIDCAB approaches, exposure is dependent on the size
of the skin incision through which the anastomosis is
performed. It is our policy to convert to sternotomy
whenever there is a concern about patient safety,
hemodynamic stability, or quality of the anastomosis,
and we do not consider conversion a failure.
CONCLUSIONS
Although this series is limited by its retrospective nature
and relatively small sample size, these results add to the
growing body of literature that minimally invasive CABG
procedures can be performed with excellent short-term
clinical and angiographic outcomes. Acknowledging that
a long learning curve exists and implementing quality
control measures such as routine intraoperative or post-
operative angiography are important components that
may optimize both clinical outcomes and graft success.
Close collaboration with the surgical team and other
providers by using a multidisciplinary approach is essential
to ensure excellent outcomes with these less-invasive
procedures.
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